Recently Added |View All
LDCT+: A New Approach in Early Lung Disease Detection - Webinar
1:00 PM - 2:00 PM EST | Wednesday, March 19, 2025
Dyspnea and dyspnea on exertion are among the most common patient complaints both in the office and in the hospital setting. While in-hospital evaluations tend to have a more acute focus, outpatient office evaluations of dyspnea tend to ...
Interstitial Lung Disease (ILD) and Associated Pulmonary Hypertension
Interstitial lung disease (ILD) is a commonly encountered disease state. Patients who develop ILD associated with pulmonary hypertension have an increased mortality risk. This program aims to review the classification of commonly encountered ...
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective ...
Temple Lung Center: Advancing Research in COPD
The Temple Lung Center is one of the world’s largest COPD research centers, and has demonstrated its commitment to offer innovative therapies to patients by applying research breakthroughs to clinical care.
Lung Transplantation for COPD Patients
Chronic Obstructive Pulmonary Disease (COPD) is the sixth leading cause of death in the U.S., affecting nearly 16 million adults. Dr. Gerard Criner, Director of the Temple Lung Center, recently joined the Global Forum on Lung Transplantation ...
November Quarterly Impact Report: The Temple Healthy Chest Initiative
The American Cancer Society is forecasting more than two million new cases of cancer to be diagnosed in the year 2024. And while the incidence rate is on the rise, cancer-related deaths continue to decline. Early detection is key to producing ...
Temple Lung Center: Advancing Research in ILD
Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide ...
A comprehensive overview of strategic clinical risk stratification, evidence-based approaches derived from clinical trials and advanced research, and essential insights into the follow-up care of patients post-pulmonary embolism (PE).
Pleural Effusions and Pleural Disease
Pleural disease is a common but frequently misunderstood clinical entity within the field of pulmonary disease. While up to 30% of individuals assessed may have pleural effusions, the specific diagnostic and therapeutic modalities undertaken ...
Advanced Bronchoscopic Services
As the only integrated pulmonary and critical care medicine, sleep medicine, and thoracic surgery department in the nation, the highly experienced, multidisciplinary team at the Temple Lung Center is consistently setting new standards ...
Presented by Temple cardiothoracic surgery and pulmonary faculty as a pre-conference activity at the January 2024 STS Annual Meeting, this symposium, “Surgical and Medical Insights for Transplant Assessment and Management” will provide ...
Lung Transplant Program Referral Information
The Temple Lung Transplant Program is a leader in both quantity and quality. It’s the nation’s highest volume program, but it also has the best one-year survival rates in Philadelphia and all of Pennsylvania.
Optimizing Treatment for CTD-ILD
When autoimmune or connective tissue diseases cause inflammation or scarring of the lungs, both diagnosis and effective management can be challenging.
Diagnosis and Treatment of Obesity-Hypoventilation Syndrome
Obesity hypoventilation syndrome (OHS) is a respiratory disorder resulting in multisystem dysfunction. This program will review the epidemiology, pathophysiology, and mortality of this disorder. Current treatment recommendations as put ...
Bronchoscopic Lung Volume Reduction in Patients with Advanced Emphysema
As part of the Pulmonology On Air 2022 Global Event, Gerard Criner, MD, FACP, FACCP, Director of the Temple Lung Center, demonstrates a LIVE endobronchial valve placement on a patient with advanced homogenous emphysema.
As the nation’s leading COPD research and treatment center, Temple sets new standards for COPD care.
Management of Early Stage Non-Small Cell Lung Cancer
Presented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education, this conference is designed as a forum for discussion of advances in technology and treatment of early stage non-small ...
While many cases of asthma can be managed in a primary care setting, 5–10% of patients have asthma that cannot be controlled by standard treatments.